Works by Knöchel, Jane


Results: 14
    1
    2
    3
    4
    5
    6
    7
    8

    An oral antisense oligonucleotide for PCSK9 inhibition.

    Published in:
    Science Translational Medicine, 2021, v. 13, n. 593, p. 1, doi. 10.1126/scitranslmed.abe9117
    By:
    • Gennemark, Peter;
    • Walter, Katrin;
    • Clemmensen, Niclas;
    • Rekić, Dinko;
    • Nilsson, Catarina A.M.;
    • Knöchel, Jane;
    • Hölttä, Mikko;
    • Wernevik, Linda;
    • Rosengren, Birgitta;
    • Kakol-Palm, Dorota;
    • Wang, Yanfeng;
    • Yu, Rosie Z.;
    • Geary, Richard S.;
    • Riney, Stan J.;
    • Monia, Brett P.;
    • Isaksson, Rikard;
    • Jansson-Löfmark, Rasmus;
    • Rocha, Cristina S. J.;
    • Lindén, Daniel;
    • Hurt-Camejo, Eva
    Publication type:
    Article
    9
    10
    11
    12

    A drug–drug interaction study and physiologically based pharmacokinetic modelling to assess the effect of an oral 5‐lipoxygenase activating protein inhibitor on the pharmacokinetics of oral midazolam.

    Published in:
    British Journal of Clinical Pharmacology, 2024, v. 90, n. 9, p. 2180, doi. 10.1111/bcp.16131
    By:
    • Knöchel, Jane;
    • Panduga, Vijender;
    • Nelander, Karin;
    • Heijer, Maria;
    • Lindstedt, Eva‐Lotte;
    • Ali, Hodan;
    • Aurell, Malin;
    • Ödesjö, Helena;
    • Forte, Pablo;
    • Connolly, Kat;
    • Ericsson, Hans;
    • MacPhee, Iain
    Publication type:
    Article
    13

    Population pharmacokinetics of a novel PCSK9 antisense oligonucleotide.

    Published in:
    British Journal of Clinical Pharmacology, 2024, v. 90, n. 6, p. 1503, doi. 10.1111/bcp.16046
    By:
    • Clewe, Oskar;
    • Rekić, Dinko;
    • Quartino, Angelica L.;
    • Carlsson, Björn;
    • Higashimori, Mitsuo;
    • Wernevik, Linda;
    • Hofherr, Alexis;
    • Rydén‐Bergsten, Tina;
    • Nilsson, Catarina;
    • Knöchel, Jane
    Publication type:
    Article
    14